Partial laryngectomy for naïve pT3N0 laryngeal cancer: Systematic review on oncological outcomes.
Flaminia CampoFrancesco MazzolaGiulia BianchiValentina MancioccoMassimo RalliAntonio GrecoIsabella SperdutiMarco de VincentiisRaul PelliniPublished in: Head & neck (2022)
The first aim was to define the oncologic outcomes of open partial laryngectomy (OPL) in naïve pT3 laryngeal cancer. The second aim was to analyze the outcomes after OPL versus total laryngectomy (TL). A literature search was conducted in three databases (MEDLINE, EMBASE, and Cochrane Library) until January 2022. In 805 patients treated with OPL, 5-year OS, DSS, DFS and LFS were 80.5% (95% CI 70.6-87.6), 83.4% (95% CI 75.7-89), 77.4% (95% CI 66.3-85.7) and 77.9% (95% CI 68.7-85), respectively. Three articles compared TL versus OLP: 5-year OS, DSS and DFS risk difference were 0.100 (95% CI -0.092 to 0.291), 0.067 (95% CI -0.085 to 0.220) and 0.018 (95% CI -0.164 to 0.201) respectively. OPL for selected pT3 laryngeal cancer is able to guarantee a high percentage of oncological success. Accurate patient selection is of utmost importance to differentiate advanced disease amenable to conservative surgery.
Keyphrases
- systematic review
- papillary thyroid
- squamous cell
- minimally invasive
- rectal cancer
- radical prostatectomy
- prostate cancer
- robot assisted
- lymph node metastasis
- randomized controlled trial
- meta analyses
- machine learning
- coronary artery disease
- mass spectrometry
- adipose tissue
- deep learning
- percutaneous coronary intervention
- coronary artery bypass
- insulin resistance
- glycemic control
- breast cancer risk